SIMCERE PHARMAC. GRP LTD (S2P) — Free Cash Flow Generation Index
SIMCERE PHARMAC. GRP LTD (S2P) has a Free Cash Flow Generation Index of 0.57x as of December 2025. Free cash flow of €1.15 Billion represents 1% of operating cash flow (€2.01 Billion). See S2P current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
SIMCERE PHARMAC. GRP LTD Free Cash Flow Generation Index (2022–2025)
Historical FCF Generation Index trend for SIMCERE PHARMAC. GRP LTD across 4 annual periods. Explore S2P debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for SIMCERE PHARMAC. GRP LTD (2022–2025)
Year-by-year Free Cash Flow Generation Index for SIMCERE PHARMAC. GRP LTD. For the full company profile including market capitalisation, see S2P market cap overview.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.57x | €1.15 Billion | €2.01 Billion | €862.20 Million | ▲ +26.6% |
| 2024 | 0.45x | €628.54 Million | €1.39 Billion | €762.57 Million | ▲ +108.2% |
| 2023 | -5.49x | €-828.81 Million | €151.05 Million | €979.86 Million | ▼ -1199.0% |
| 2022 | 0.50x | €676.09 Million | €1.35 Billion | €678.00 Million | — |